By Sneha S K and Sahil Pandey April 15 (Reuters) - Cosmo Pharmaceuticals said on Wednesday its experimental hair loss treatment showed sustained hair growth and long-term safety in men with common ...

For an almost minimalist twist on Cosmo nails, look to this short manicure. Muted green cutouts reveal slivers of shocking ...

Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) announced that its shareholders approved all voting items at today’s Ordinary Annual General Meeting (AGM). A total of 10,354,065 ordinary ...

Cosmo Pharmaceuticals has revealed topline results from two phase 3 trials which indicate that its topical cream clascoterone could become a game-changing treatment for male-pattern hair loss. The ...